Bilim Pharmaceuticals

Bilim Pharmaceuticals is a major, privately-held Turkish generics company with a 70-year history. It holds a top-five market position in Turkey, ranking second overall in 2022, and leads in physician prescription preferences within its operating segments. The company's strategy is built on a wide product portfolio, a substantial sales and marketing organization, and investments in R&D and manufacturing to develop generic versions of patent-expiring originals. Its steady growth is anchored in the large Turkish pharmaceutical market.

Small-molecule generic drug development and manufacturing, with R&D focused on bioequivalence studies and process development for patent-expiring originals. Manufacturing technology includes GMP facilities for solid, liquid, semi-solid, sterile liquid, and penicillin products.

Operates in the highly competitive Turkish generics market with 753 companies. Bilim holds a strong position as the #2 player overall and leads in physician prescription preference within its key segments (antibiotics, respiratory, musculoskeletal). Competes with other large domestic players and multinational generics companies on portfolio breadth, price, and commercial relationships.